Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 5166 (109th)

Independent Pharmacy Protection Act of 2006

referredUnited States· United States Congress· EN

Introduced

6 April 2006

Last action

19 April 2006 · Referred

Status

Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman .

Sponsors

Sen. Wicker, Roger F. [R-MS], Rep. LoBiondo, Frank A. [R-NJ-2], Rep. Pickering, Charles W. "Chip" [R-MS-3], Rep. Bonner, Jo [R-AL-1], Sen. Brown, Sherrod [D-OH], Rep. Peterson, John E. [R-PA-5], Rep. Cubin, Barbara [R-WY-At Large], Rep. Everett, Terry [R-AL-2], Rep. Bachus, Spencer [R-AL-6], Rep. Davis, Geoff [R-KY-4], Rep. Boustany, Charles W., Jr. [R-LA-3], Rep. Sodrel, Michael E. [R-IN-9], Rep. Conaway, K. Michael [R-TX-11], Rep. Fortenberry, Jeff [R-NE-1], Rep. Harris, Katherine [R-FL-13], Rep. Whitfield, Ed [R-KY-1], Rep. Bilirakis, Michael [R-FL-9], Rep. Emerson, Jo Ann [R-MO-8], Rep. Pryce, Deborah [R-OH-15], Rep. Schwarz, John J.H. "Joe" [R-MI-7], Rep. Foley, Mark [R-FL-16], Rep. Leach, James A. [R-IA-2], Rep. Gerlach, Jim [R-PA-6], Rep. Walden, Greg [R-OR-2], Rep. Davis, Jo Ann [R-VA-1], Rep. Sherwood, Don [R-PA-10], Sen. Boozman, John [R-AR], Rep. Osborne, Tom [R-NE-3], Rep. Doolittle, John T. [R-CA-4], Rep. Tiahrt, Todd [R-KS-4], Rep. Burgess, Michael C. [R-TX-26], Rep. Akin, W. Todd [R-MO-2], Rep. Aderholt, Robert B. [R-AL-4], Sen. Blunt, Roy [R-MO], Rep. McHenry, Patrick T. [R-NC-10], Rep. Foxx, Virginia [R-NC-5], Rep. Pence, Mike [R-IN-6], Rep. Bishop, Rob [R-UT-1], Rep. Garrett, Scott [R-NJ-5], Rep. Hoekstra, Peter [R-MI-2], Rep. Fitzpatrick, Michael G. [R-PA-8], Rep. Kaptur, Marcy [D-OH-9], Rep. Gutknecht, Gil [R-MN-1], Rep. Wasserman Schultz, Debbie [D-FL-25], Sen. Van Hollen, Chris [D-MD], Rep. Wexler, Robert [D-FL-19], Rep. English, Phil [R-PA-3], Rep. Wilson, Joe [R-SC-2]

Subjects

Healthcare

Source updated

15 August 2025

Healthcare

Summary

Independent Pharmacy Protection Act of 2006 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require each prescription drug plan contract entered into with a plan sponsor to provide for: (1) the availability of direct deposit payments; (2) an increased dispensing fee for generic drugs; and (3) payments within 10 days for certain pharmacies. Requires the dispensing fee paid to a participating pharmacy for a generic covered part D drug therapeutically equivalent and bioequivalent to a brand name covered part D drug dispensed through the pharmacy to be at least 50% greater than the dispensing fee for the brand name drug. Limits to $10 the dispensing fee paid to a participating pharmacy for a generic covered part D drug. Prohibits a prescription drug plan, subject to exception by the Secretary of Health and Human Services, from decreasing the dispensing fee paid to a participating pharmacy for a brand name drug to an amount less than the dispensing fee paid for it on the date of enactment of this Act. Applies this Act to contracts with a Medicare Advantage organization in the same manner as they apply to those with a prescription drug plan sponsor.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 6 April 2006

    Introduced

    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 6 April 2006

    Introduced

    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 6 April 2006

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 6 April 2006

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 19 April 2006

    Referred

    Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman .

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 6 April 2006

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 6 April 2006

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 6 April 2006

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 189 sponsors and actors.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.